Tapewire

Nasdaq · USD

CTXR

Citius Pharmaceuticals, Inc.

Export transactions ↓
Tapewire entity
7778
SEC CIK
0001506251
Parsed reports
102

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 08, 2025 Filed Aug 12, 2025 16:51 UTC
HOLUBIAK MYRON ZDirector · Vice Chairman
GrantWarrant to Purchase Common Stock · Derivative 22,344 Not disclosed Strike: $19.25 Not disclosed
Disclosure

SEC source: 0001213900-25-075035 · ownership.xml · derivative · entry 5

HOLUBIAK MYRON Z · CIK 0001199080 · Director · Vice Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,344

Underlying: Common Stock · 22,344 shares

Expires 2026-09-27

F4 · security: The options are held by the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares.

F2 · kind: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately.

F2 · price: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately.

F2 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately.

Read SEC document
August 08, 2025 Filed Aug 12, 2025 16:51 UTC
HOLUBIAK MYRON ZDirector · Vice Chairman
Disposition to issuerWarrant to Purchase Common Stock · Derivative 22,344 Not disclosed Strike: $19.25 Not disclosed
Disclosure

SEC source: 0001213900-25-075035 · ownership.xml · derivative · entry 4

HOLUBIAK MYRON Z · CIK 0001199080 · Director · Vice Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 22,344 shares

Expires 2025-09-27

F2 · security: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately.

F2 · kind: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately.

F2 · price: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately.

F2 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately.

Read SEC document
August 08, 2025 Filed Aug 12, 2025 16:51 UTC
HOLUBIAK MYRON ZDirector · Vice Chairman
GrantWarrant to Purchase Common Stock · Derivative 31,373 Not disclosed Strike: $28.75 Not disclosed
Disclosure

SEC source: 0001213900-25-075035 · ownership.xml · derivative · entry 3

HOLUBIAK MYRON Z · CIK 0001199080 · Director · Vice Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,373

Underlying: Common Stock · 31,373 shares

Expires 2026-08-14

F1 · security: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately.

F1 · kind: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately.

F1 · price: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately.

F1 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately.

Read SEC document
August 08, 2025 Filed Aug 12, 2025 16:51 UTC
HOLUBIAK MYRON ZDirector · Vice Chairman
Disposition to issuerWarrant to Purchase Common Stock · Derivative 31,373 Not disclosed Strike: $28.75 Not disclosed
Disclosure

SEC source: 0001213900-25-075035 · ownership.xml · derivative · entry 2

HOLUBIAK MYRON Z · CIK 0001199080 · Director · Vice Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 31,373 shares

Expires 2025-08-14

F1 · security: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately.

F1 · kind: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately.

F1 · price: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately.

F1 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately.

Read SEC document
August 08, 2025 Filed Sep 23, 2025 16:05 UTC
Mazur Leonard LDirector · Chief Executive Officer
GrantWarrant to Purchase Common Stock · Derivative 89,388 Not disclosed Strike: $19.25 Not disclosed
Disclosure

SEC source: 0001213900-25-090602 · ownership.xml · derivative · entry 5

Mazur Leonard L · CIK 0001463414 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 89,388

Underlying: Common Stock · 89,388 shares

Expires 2026-09-27

F2 · security: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately.

F2 · kind: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately.

F2 · price: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately.

F2 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately.

Read SEC document
August 08, 2025 Filed Sep 23, 2025 16:05 UTC
Mazur Leonard LDirector · Chief Executive Officer
Disposition to issuerWarrant to Purchase Common Stock · Derivative 89,388 Not disclosed Strike: $19.25 Not disclosed
Disclosure

SEC source: 0001213900-25-090602 · ownership.xml · derivative · entry 4

Mazur Leonard L · CIK 0001463414 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 89,388 shares

Expires 2025-09-27

F2 · security: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately.

F2 · kind: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately.

F2 · price: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately.

F2 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately.

Read SEC document
August 08, 2025 Filed Sep 23, 2025 16:05 UTC
Mazur Leonard LDirector · Chief Executive Officer
GrantWarrant to Purchase Common Stock · Derivative 125,490 Not disclosed Strike: $28.75 Not disclosed
Disclosure

SEC source: 0001213900-25-090602 · ownership.xml · derivative · entry 3

Mazur Leonard L · CIK 0001463414 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,490

Underlying: Common Stock · 125,490 shares

Expires 2026-08-14

F1 · security: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately.

F1 · kind: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately.

F1 · price: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately.

F1 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately.

Read SEC document
August 08, 2025 Filed Sep 23, 2025 16:05 UTC
Mazur Leonard LDirector · Chief Executive Officer
Disposition to issuerWarrant to Purchase Common Stock · Derivative 125,490 Not disclosed Strike: $28.75 Not disclosed
Disclosure

SEC source: 0001213900-25-090602 · ownership.xml · derivative · entry 2

Mazur Leonard L · CIK 0001463414 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 125,490 shares

Expires 2025-08-14

F1 · security: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately.

F1 · kind: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately.

F1 · price: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately.

F1 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately.

Read SEC document
November 07, 2024 Filed Nov 12, 2024 17:00 UTC GrantStock Option (Right to Purchase Common Stock) · Derivative 125,000 $0.00 Strike: $0.38 $0.00
Disclosure

SEC source: 0001213900-24-096894 · ownership.xml · derivative · entry 1

Smith Robert Joseph · CIK 0002008764 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2034-11-07

F1 · derivative.exercise_date: The options were granted on November 7, 2024. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.

Read SEC document
November 07, 2024 Filed Nov 12, 2024 17:00 UTC
Czuczman MyronChief Medical Officer
GrantStock Option (Right to Purchase Common Stock) · Derivative 300,000 $0.00 Strike: $0.38 $0.00
Disclosure

SEC source: 0001213900-24-096891 · ownership.xml · derivative · entry 1

Czuczman Myron · CIK 0001817716 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Common Stock · 300,000 shares

Expires 2034-11-07

F1 · derivative.exercise_date: The options were granted on November 7, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.

Read SEC document
November 07, 2024 Filed Nov 12, 2024 17:00 UTC
Webb CarolDirector
GrantStock Option (Right to Purchase Common Stock) · Derivative 125,000 $0.00 Strike: $0.38 $0.00
Disclosure

SEC source: 0001213900-24-096895 · ownership.xml · derivative · entry 2

Webb Carol · CIK 0001671111 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2034-11-07

F1 · derivative.exercise_date: The options were granted on November 7, 2024. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.

Read SEC document
November 07, 2024 Filed Nov 12, 2024 17:00 UTC
Mazur Leonard LDirector · Chief Executive Officer · 10% owner
GrantStock Option (Right to Purchase Common Stock) · Derivative 600,000 $0.00 Strike: $0.38 $0.00
Disclosure

SEC source: 0001213900-24-096892 · ownership.xml · derivative · entry 2

Mazur Leonard L · CIK 0001463414 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 600,000

Underlying: Common Stock · 600,000 shares

Expires 2034-11-07

F1 · derivative.exercise_date: The options were granted on November 7, 2024. The options vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.

Read SEC document
November 07, 2024 Filed Nov 12, 2024 22:00 UTC GrantStock Option (Right to Purchase Common Stock) · Derivative 125,000 $0.00 Strike: $0.38 $0.00
Disclosure

SEC source: 0001213900-24-096889 · ownership.xml · derivative · entry 1

MCGRATH DENNIS M · CIK 0001269340 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2034-11-07

F1 · derivative.exercise_date: The options were granted on November 7, 2024. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.

Read SEC document
November 07, 2024 Filed Nov 12, 2024 17:00 UTC
HOLUBIAK MYRON ZDirector · Vice Chairman
GrantStock Option (Right to Buy) · Derivative 75,000 $0.00 Strike: $0.38 $0.00
Disclosure

SEC source: 0001213900-24-096888 · ownership.xml · derivative · entry 3

HOLUBIAK MYRON Z · CIK 0001199080 · Director · Vice Chairman

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2034-11-07

F2 · derivative.exercise_date: The options are held by the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares.

F2 · ownership.nature: The options are held by the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares.

Read SEC document
November 07, 2024 Filed Nov 12, 2024 17:00 UTC
HOLUBIAK MYRON ZDirector · Vice Chairman
GrantStock Option (Right to Purchase Common Stock) · Derivative 350,000 $0.00 Strike: $0.38 $0.00
Disclosure

SEC source: 0001213900-24-096888 · ownership.xml · derivative · entry 2

HOLUBIAK MYRON Z · CIK 0001199080 · Director · Vice Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 350,000

Underlying: Common Stock · 350,000 shares

Expires 2034-11-07

F1 · derivative.exercise_date: The options were granted on November 7, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.

Read SEC document
November 07, 2024 Filed Nov 12, 2024 22:00 UTC
Bartushak JaimeChief Financial Officer
GrantStock Option (Right to Purchase Common Stock) · Derivative 350,000 $0.00 Strike: $0.38 $0.00
Disclosure

SEC source: 0001213900-24-096893 · ownership.xml · derivative · entry 2

Bartushak Jaime · CIK 0001725077 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 350,000

Underlying: Common Stock · 350,000 shares

Expires 2034-11-07

F1 · derivative.exercise_date: The options were granted on November 7, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date

Read SEC document
November 07, 2024 Filed Nov 12, 2024 22:00 UTC GrantStock Option (Right to Purchase Common Stock) · Derivative 125,000 $0.00 Strike: $0.38 $0.00
Disclosure

SEC source: 0001213900-24-096890 · ownership.xml · derivative · entry 1

Dutia Suren G · CIK 0001514063 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2034-11-07

F1 · derivative.exercise_date: The options were granted on November 7, 2024. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.

Read SEC document
November 07, 2024 Filed Nov 12, 2024 22:00 UTC GrantStock Option (Right to Purchase Common Stock) · Derivative 125,000 $0.00 Strike: $0.38 $0.00
Disclosure

SEC source: 0001213900-24-096887 · ownership.xml · derivative · entry 2

Holuka Eugene Myron · CIK 0001678292 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2034-11-07

F1 · derivative.exercise_date: The options were granted on November 7, 2024. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.

Read SEC document
September 25, 2024 Filed Sep 27, 2024 17:26 UTC
Mazur Leonard LDirector · Chief Executive Officer · 10% owner
GrantWarrant to Purchase Common Stock · Derivative 2,234,700 Not disclosed Strike: $0.77 Not disclosed
Disclosure

SEC source: 0001213900-24-082812 · ownership.xml · derivative · entry 5

Mazur Leonard L · CIK 0001463414 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,234,700

Underlying: Common Stock · 2,234,700 shares

Expires 2025-09-27

F2 · security: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately.

F2 · kind: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately.

F2 · price: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately.

F2 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately.

Read SEC document
September 25, 2024 Filed Sep 27, 2024 17:26 UTC
Mazur Leonard LDirector · Chief Executive Officer · 10% owner
Disposition to issuerWarrant to Purchase Common Stock · Derivative 2,234,700 Not disclosed Strike: $0.77 Not disclosed
Disclosure

SEC source: 0001213900-24-082812 · ownership.xml · derivative · entry 4

Mazur Leonard L · CIK 0001463414 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,234,700 shares

Expires 2024-09-27

F2 · security: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately.

F2 · kind: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately.

F2 · price: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately.

F2 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately.

Read SEC document
September 25, 2024 Filed Sep 27, 2024 17:27 UTC
HOLUBIAK MYRON ZDirector · Vice Chairman
GrantWarrant to Purchase Common Stock · Derivative 558,597 Not disclosed Strike: $0.77 Not disclosed
Disclosure

SEC source: 0001213900-24-082813 · ownership.xml · derivative · entry 5

HOLUBIAK MYRON Z · CIK 0001199080 · Director · Vice Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 558,597

Underlying: Common Stock · 558,597 shares

Expires 2025-09-27

F2 · security: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately.

F2 · kind: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately.

F2 · price: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately.

F2 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately.

Read SEC document
September 25, 2024 Filed Sep 27, 2024 17:27 UTC
HOLUBIAK MYRON ZDirector · Vice Chairman
Disposition to issuerWarrant to Purchase Common Stock · Derivative 558,597 Not disclosed Strike: $0.77 Not disclosed
Disclosure

SEC source: 0001213900-24-082813 · ownership.xml · derivative · entry 4

HOLUBIAK MYRON Z · CIK 0001199080 · Director · Vice Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 558,597 shares

Expires 2024-09-27

F2 · security: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately.

F2 · kind: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately.

F2 · price: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately.

F2 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately.

Read SEC document
August 14, 2024 Filed Sep 27, 2024 17:26 UTC
Mazur Leonard LDirector · Chief Executive Officer · 10% owner
GrantWarrant to Purchase Common Stock · Derivative 3,137,255 Not disclosed Strike: $1.15 Not disclosed
Disclosure

SEC source: 0001213900-24-082812 · ownership.xml · derivative · entry 3

Mazur Leonard L · CIK 0001463414 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,137,255

Underlying: Common Stock · 3,137,255 shares

Expires 2025-08-14

F1 · security: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately.

F1 · kind: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately.

F1 · price: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately.

F1 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately.

Read SEC document
August 14, 2024 Filed Sep 27, 2024 17:26 UTC
Mazur Leonard LDirector · Chief Executive Officer · 10% owner
Disposition to issuerWarrant to Purchase Common Stock · Derivative 3,137,255 Not disclosed Strike: $1.15 Not disclosed
Disclosure

SEC source: 0001213900-24-082812 · ownership.xml · derivative · entry 2

Mazur Leonard L · CIK 0001463414 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,137,255 shares

Expires 2024-08-14

F1 · security: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately.

F1 · kind: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately.

F1 · price: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately.

F1 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately.

Read SEC document
August 14, 2024 Filed Sep 27, 2024 17:27 UTC
HOLUBIAK MYRON ZDirector · Vice Chairman
GrantWarrant to Purchase Common Stock · Derivative 784,314 Not disclosed Strike: $1.15 Not disclosed
Disclosure

SEC source: 0001213900-24-082813 · ownership.xml · derivative · entry 3

HOLUBIAK MYRON Z · CIK 0001199080 · Director · Vice Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 784,314

Underlying: Common Stock · 784,314 shares

Expires 2025-08-14

F1 · security: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately.

F1 · kind: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately.

F1 · price: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately.

F1 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately.

Read SEC document
August 14, 2024 Filed Sep 27, 2024 17:27 UTC
HOLUBIAK MYRON ZDirector · Vice Chairman
Disposition to issuerWarrant to Purchase Common Stock · Derivative 784,314 Not disclosed Strike: $1.15 Not disclosed
Disclosure

SEC source: 0001213900-24-082813 · ownership.xml · derivative · entry 2

HOLUBIAK MYRON Z · CIK 0001199080 · Director · Vice Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 784,314 shares

Expires 2024-08-14

F1 · security: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately.

F1 · kind: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately.

F1 · price: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately.

F1 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately.

Read SEC document
April 03, 2024 Filed Apr 5, 2024 16:05 UTC
Mazur Leonard LDirector · Chief Executive Officer · 10% owner
GrantWarrant to Purchase Common Stock · Derivative 1,165,048 Not disclosed Strike: $1.42 Not disclosed
Disclosure

SEC source: 0001213900-24-030811 · ownership.xml · derivative · entry 3

Mazur Leonard L · CIK 0001463414 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,165,048

Underlying: Common Stock · 1,165,048 shares

Expires 2025-04-05

F1 · security: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately.

F1 · kind: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately.

F1 · price: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately.

F1 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately.

Read SEC document
April 03, 2024 Filed Apr 5, 2024 16:05 UTC
Mazur Leonard LDirector · Chief Executive Officer · 10% owner
Disposition to issuerWarrant to Purchase Common Stock · Derivative 1,165,048 Not disclosed Strike: $1.42 Not disclosed
Disclosure

SEC source: 0001213900-24-030811 · ownership.xml · derivative · entry 2

Mazur Leonard L · CIK 0001463414 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,165,048 shares

Expires 2024-04-05

F1 · security: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately.

F1 · kind: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately.

F1 · price: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately.

F1 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately.

Read SEC document
April 03, 2024 Filed Apr 5, 2024 16:05 UTC
HOLUBIAK MYRON ZDirector · Vice Chairman
GrantWarrant to Purchase Common Stock · Derivative 129,450 Not disclosed Strike: $1.42 Not disclosed
Disclosure

SEC source: 0001213900-24-030812 · ownership.xml · derivative · entry 3

HOLUBIAK MYRON Z · CIK 0001199080 · Director · Vice Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 129,450

Underlying: Common Stock · 129,450 shares

Expires 2025-04-05

F1 · security: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately.

F1 · kind: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately.

F1 · price: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately.

F1 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately.

Read SEC document
April 03, 2024 Filed Apr 5, 2024 16:05 UTC
HOLUBIAK MYRON ZDirector · Vice Chairman
Disposition to issuerWarrant to Purchase Common Stock · Derivative 129,450 Not disclosed Strike: $1.42 Not disclosed
Disclosure

SEC source: 0001213900-24-030812 · ownership.xml · derivative · entry 2

HOLUBIAK MYRON Z · CIK 0001199080 · Director · Vice Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 129,450 shares

Expires 2024-04-05

F1 · security: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately.

F1 · kind: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately.

F1 · price: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately.

F1 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately.

Read SEC document
March 14, 2024 Filed Mar 18, 2024 16:06 UTC GrantStock Option (Right to Purchase Common Stock) · Derivative 75,000 $0.00 Strike: $0.69 $0.00
Disclosure

SEC source: 0001213900-24-023487 · ownership.xml · derivative · entry 1

Smith Robert Joseph · CIK 0002008764 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2034-03-12

F1 · derivative.exercise_date: The options were granted on March 14, 2024, with a Vesting Commencement Date of March 12, 2024, the date of the Optionee's election to the Board of the Company. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.

Read SEC document
March 13, 2024 Filed Aug 30, 2024 20:01 UTC Exercise / conversionStock Option (Right to Purchase Common Stock) · Derivative 2,415 $0.00 Strike: $0.02 $0.00
Disclosure

SEC source: 0001213900-24-074506 · ownership.xml · derivative · entry 3

Holuka Eugene Myron · CIK 0001678292 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,415 shares

Expires 2024-04-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 13, 2024 Filed Aug 30, 2024 20:01 UTC Tax withholdingCommon Stock 48 $0.75 $36.00
Disclosure

SEC source: 0001213900-24-074506 · ownership.xml · nonDerivative · entry 2

Holuka Eugene Myron · CIK 0001678292 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,367

Read SEC document
March 13, 2024 Filed Aug 30, 2024 20:01 UTC Exercise / conversionCommon Stock 2,415 $0.02 $36.23
Disclosure

SEC source: 0001213900-24-074506 · ownership.xml · nonDerivative · entry 1

Holuka Eugene Myron · CIK 0001678292 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,415

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 04, 2024 Filed Aug 30, 2024 16:01 UTC
Webb CarolDirector
Exercise / conversionStock Option (Right to Purchase Common Stock) · Derivative 12,071 $0.00 Strike: $0.02 $0.00
Disclosure

SEC source: 0001213900-24-074505 · ownership.xml · derivative · entry 3

Webb Carol · CIK 0001671111 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,071 shares

Expires 2024-03-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 04, 2024 Filed Aug 30, 2024 16:01 UTC
Webb CarolDirector
Tax withholdingCommon Stock 236 $0.77 $180.78
Disclosure

SEC source: 0001213900-24-074505 · ownership.xml · nonDerivative · entry 2

Webb Carol · CIK 0001671111 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,835

Read SEC document
March 04, 2024 Filed Aug 30, 2024 16:01 UTC
Webb CarolDirector
Exercise / conversionCommon Stock 12,071 $0.02 $181.07
Disclosure

SEC source: 0001213900-24-074505 · ownership.xml · nonDerivative · entry 1

Webb Carol · CIK 0001671111 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,071

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 10, 2023 Filed Oct 12, 2023 16:15 UTC
Czuczman MyronChief Medical Officer
GrantStock Option (Right to Purchase Common Stock) · Derivative 300,000 $0.00 Strike: $0.70 $0.00
Disclosure

SEC source: 0001013762-23-003534 · ownership.xml · derivative · entry 1

Czuczman Myron · CIK 0001817716 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Common Stock · 300,000 shares

Expires 2033-10-10

F1 · derivative.exercise_date: The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.

Read SEC document
October 10, 2023 Filed Oct 12, 2023 16:15 UTC
Webb CarolDirector
GrantOptions to Purchase Common Stock · Derivative 75,000 $0.00 Strike: $0.70 $0.00
Disclosure

SEC source: 0001013762-23-003535 · ownership.xml · derivative · entry 1

Webb Carol · CIK 0001671111 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2033-10-10

F1 · security: The options were granted on October 10, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.

F1 · derivative.exercise_date: The options were granted on October 10, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.

Read SEC document
October 10, 2023 Filed Oct 12, 2023 16:15 UTC
Mazur Leonard LDirector · Chief Executive Officer · 10% owner
GrantOption to Purchase Common Stock · Derivative 550,000 $0.00 Strike: $0.70 $0.00
Disclosure

SEC source: 0001013762-23-003528 · ownership.xml · derivative · entry 13

Mazur Leonard L · CIK 0001463414 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 550,000

Underlying: Common Stock · 550,000 shares

Expires 2033-10-10

F10 · security: The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.

F10 · derivative.exercise_date: The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.

Read SEC document
October 10, 2023 Filed Oct 12, 2023 20:15 UTC GrantOptions to Purchase Common Stock · Derivative 75,000 $0.00 Strike: $0.70 $0.00
Disclosure

SEC source: 0001013762-23-003529 · ownership.xml · derivative · entry 1

MCGRATH DENNIS M · CIK 0001269340 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2033-10-10

F1 · security: The options were granted on October 10, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.

F1 · derivative.exercise_date: The options were granted on October 10, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.

Read SEC document
October 10, 2023 Filed Oct 12, 2023 16:15 UTC
HOLUBIAK MYRON ZDirector · Vice Chairman
GrantOptions to Purchase Common Stock · Derivative 400,000 $0.00 Strike: $0.70 $0.00
Disclosure

SEC source: 0001013762-23-003533 · ownership.xml · derivative · entry 15

HOLUBIAK MYRON Z · CIK 0001199080 · Director · Vice Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 400,000

Underlying: Common Stock · 400,000 shares

Expires 2033-10-10

F11 · security: The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.

F11 · derivative.exercise_date: The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.

Read SEC document
October 10, 2023 Filed Oct 12, 2023 20:15 UTC GrantOptions to Purchase Common Stock · Derivative 75,000 $0.00 Strike: $0.70 $0.00
Disclosure

SEC source: 0001013762-23-003532 · ownership.xml · derivative · entry 1

Holuka Eugene Myron · CIK 0001678292 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2033-10-10

F1 · security: The options were granted on October 10, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.

F1 · derivative.exercise_date: The options were granted on October 10, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.

Read SEC document
October 10, 2023 Filed Oct 12, 2023 20:15 UTC GrantOptions to Purchase Common Stock · Derivative 75,000 $0.00 Strike: $0.70 $0.00
Disclosure

SEC source: 0001013762-23-003531 · ownership.xml · derivative · entry 1

Dutia Suren G · CIK 0001514063 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2033-10-10

F1 · security: The options were granted on October 10, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.

F1 · derivative.exercise_date: The options were granted on October 10, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.

Read SEC document
October 10, 2023 Filed Oct 12, 2023 20:15 UTC
Bartushak JaimeChief Financial Officer
GrantStock Option (Right to Purchase Common Stock) · Derivative 300,000 $0.00 Strike: $0.70 $0.00
Disclosure

SEC source: 0001013762-23-003530 · ownership.xml · derivative · entry 2

Bartushak Jaime · CIK 0001725077 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Common Stock · 300,000 shares

Expires 2033-10-10

F1 · security: The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date.

F1 · derivative.exercise_date: The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date.

Read SEC document
February 07, 2023 Filed Feb 9, 2023 21:06 UTC GrantOptions to Purchase Common Stock · Derivative 75,000 $0.00 Strike: $1.42 $0.00
Disclosure

SEC source: 0001213900-23-009756 · ownership.xml · derivative · entry 1

MCGRATH DENNIS M · CIK 0001269340 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2033-02-07

F1 · security: The options were granted on February 7, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.

F1 · derivative.exercise_date: The options were granted on February 7, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.

Read SEC document
October 04, 2022 Filed Oct 6, 2022 16:05 UTC
Czuczman MyronChief Medical Officer
GrantStock Option (Right to Purchase Common Stock) · Derivative 300,000 $0.00 Strike: $1.25 $0.00
Disclosure

SEC source: 0001213900-22-062472 · ownership.xml · derivative · entry 1

Czuczman Myron · CIK 0001817716 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Common Stock · 300,000 shares

Expires 2032-10-04

F1 · derivative.exercise_date: The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.

Read SEC document
October 04, 2022 Filed Oct 6, 2022 16:10 UTC
Kane WilliamDirector
GrantOptions to Purchase Common Stock · Derivative 75,000 $0.00 Strike: $1.25 $0.00
Disclosure

SEC source: 0001213900-22-062485 · ownership.xml · derivative · entry 1

Kane William · CIK 0001671585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2032-10-04

F1 · security: The options were granted on October 4, 2022. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.

F1 · derivative.exercise_date: The options were granted on October 4, 2022. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.

Read SEC document
October 04, 2022 Filed Oct 6, 2022 16:06 UTC
Webb CarolDirector
GrantOptions to Purchase Common Stock · Derivative 75,000 $0.00 Strike: $1.25 $0.00
Disclosure

SEC source: 0001213900-22-062475 · ownership.xml · derivative · entry 1

Webb Carol · CIK 0001671111 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2032-10-04

F1 · security: The options were granted on October 4, 2022. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.

F1 · derivative.exercise_date: The options were granted on October 4, 2022. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.

Read SEC document
October 04, 2022 Filed Oct 6, 2022 16:08 UTC
Mazur Leonard LDirector · Executive Chairman · 10% owner
GrantOption to Purchase Common Stock · Derivative 550,000 $0.00 Strike: $1.25 $0.00
Disclosure

SEC source: 0001213900-22-062481 · ownership.xml · derivative · entry 16

Mazur Leonard L · CIK 0001463414 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 550,000

Underlying: Common Stock · 550,000 shares

Expires 2032-10-04

F9 · security: The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.

F9 · derivative.exercise_date: The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.